The incorporation of nucleoside analogs by human immunodeficiency virus type 1 reverse transcriptase decreases in the presence of polyamines

FEBS Letters

Volumn 580, Issue 22, 2006, Pages 5363-5370

  Bakhanashvili, Mary ^a,b   Rahav, Galia ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

DNA synthesis; HIV 1; Nucleoside analogs; Polyamines; Reverse transcriptase

Indexed keywords

2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; DNA; NUCLEOSIDE ANALOG; POLYAMINE; PUTRESCINE; RNA; RNA DIRECTED DNA POLYMERASE; SPERMIDINE; SPERMINE;

ARTICLE; CHEMICAL PROCEDURES; DNA SYNTHESIS; GENETIC TRANSCRIPTION; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; REDUCTION;

DIDEOXYNUCLEOSIDES; DNA, COMPLEMENTARY; HIV-1 REVERSE TRANSCRIPTASE; POLYAMINES; REVERSE TRANSCRIPTASE INHIBITORS; REVERSE TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33748779568     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.08.074     Document Type: Article

References (34)

1. De Clerq E. HIV inhibitors targeted at the reverse transcriptase. AIDS Res. Hum. Retrov. 8 (1992) 119-134
2. Goff S.P. Retroviral reverse transcriptase: synthesis, structure, and function. J. AIDS 3 (1990) 817-831
3. Perrino F.W., Preston B.D., Sandell L.L., and Loeb L.A. Extension of mismatched 3′ termini of DNA is a major determinant of the infidelity of human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl. Acad. Sci. USA 86 (1989) 8343-8347
4. Roberts J.D., Bebenek K., and Kunkel T.A. The accuracy of reverse transcriptase from HIV-1. Science 242 (1989) 1171-1173
5. Bakhanashvili M., and Hizi A. Fidelity of the reverse transcriptase of human immunodeficiency virus type 2. FEBS Lett. 306 (1992) 151-156
6. Bakhanashvili M., and Hizi A. The fidelity of the RNA-dependent DNA synthesis exhibited by the reverse transcriptases of human immunodeficiency viruses types 1 and 2 and of murine leukemia virus: mispair extension frequencies. Biochemistry 31 (1992) 9393-9398
7. Ji J., and Loeb L.A. Fidelity of HIV-1 reverse transcriptase copying RNA in vitro. Biochemistry 3 (1992) 7566-7572
8. Sluis-Cremer N., Arion D., and Parniak M.A. Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs). Cell. Mol. Life Sci. 57 (2000) 1408-1422
9. Mitsuya H., and Broder S. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc. Natl. Acad. Sci. USA 83 (1986) 1911-1915
10. Reardon J.E., and Miller W.H. Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5′-triphosphate and 3′-azido-3′-deoxythymidine 5′-triphosphate. J. Biol. Chem. 265 (1990) 20302-20307
11. Svarovskaia E.S., Cheslock S.R., Zhang W., Hu W., and Pathak V.K. Retroviral mutation rates and reverse transcriptase fidelity. Front. Biosci. 8 (2003) d117-d134
12. Bakhanashvili .M., Novitsky E., Levy I., and Rahav G. The fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase increases in the presence of polyamines. FEBS Lett. 579 (2005) 1435-1440
13. Zhang H., Dornadula G., and Pomerantz R.J. Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenvironments; an important stage for viral infection of nondividing cells. J. Virol. 70 (1996) 2809-2824
14. Thomas T., and Thomas T.J. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell. Mol. Life Sci. 58 (2001) 244-258
15. Igarashi K., and Kashiwagi K. Polyamines: mysterious modulators of cellular functions. Biochem. Biophys. Res. Comm. 271 (2000) 559-564
16. Koza R.A., and Herbst E.J. Deficiencies in DNA replication and cell-cycle progression in polyamine-depleted Hela cells. Biochem. J. 281 (1992) 87-93
17. Tabor C.W., and Tabor H. Polyamines. Ann. Rev. Biochem. 53 (1984) 749-790
18. Tyms A.S., Scamans E., and Williamson J.D. Polyamine metabolism in MRC5 cells infected with different herpes viruses. Biochem. Biophys. Res. Commun. 86 (1979) 312-318
19. Clarke J.R., and Tyms A.S. Polyamine biosynthesis in cells infected with different clinical isolates of human cytomegalovirus. J. Med. Virol. 34 (1991) 212-216
20. Colombatto S., De Agostini M., Corsi D., and Sinicco A. Polyamines in lymphocytes from patients infected by human immunodeficiency virus. Biol. Chem. Hoppe Seyler. 370 (1989) 745-748
21. Hizi A., McGill C., and Hughes S.H. Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants. Proc. Natl. Acad. Sci. USA 85 (1988) 1218-1222
22. Clark P.K., Ferris A.L., Miller D.A., Hizi A., Kim K.W., Deringer-Boyer S.M., Mellini M.L., Clark A.D., Arnold G.F., Lebherg W.B., Arnold III E., Muschik G.M., and Hughes S.H. HIV-1 reverse transcriptase purified from a recombinant strain of Escherichia coli. AIDS Res. Hum. Retrov. 6 (1990) 753-764
23. Bakhanashvili M., and Hizi A. Fidelity of DNA synthesis exhibited in vitro by the reverse transcriptase of the lentivirus-equine infectious anemia virus. Biochemistry 32 (1993) 7559-7567
24. Bakhanashvili M., and Hizi A. Interaction of the reverse transcriptase of human immunodeficiency virus type-1 with DNA. Biochemistry 33 (1994) 12222-12228
25. Ha H.C., Sirisoma N.S., Kuppusamy P., Zweier J.L., Woster P.M., and Casero R.A. The natural polyamine spermine functions directly as a free radical scavenger. Proc. Natl. Acad. Sci. USA 95 (1998) 11140-11145
26. Mansky L.M., and Temin H.M. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69 (1995) 5087-5094
27. Mansky L.M. The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene. Virology 222 (1996) 391-400
28. Bakhanashvili M., Novitsky E., Lilling G., and Rahav G. p53 in cytoplasm may enhance the accuracy of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. Oncogene 23 (2004) 6890-6899
29. Bakhanashvili M., Novitsky E., Rubinstein E., Levy I., and Rahav G. Excision of nucleoside analogs from DNA by p53 protein, a potential cellular mechanism of resistance to inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Antimic. Agents Chemoth. 49 (2005) 1576-1579
30. 2+ dependency of HIV-1 reverse transcription, inhibition by nucleoside analogues and resistance. Nucl. Acids Res. 34 (2006) 42-52
31. Menendez-Arias L. Molecular basis of fidelity of DNA synthesis and nucleotide specificity of retroviral reverse transcriptases. Prog. Nucl. Acid Res. Mol. Biol 71 (2002) 91-147
32. Arion D., and Parniak MA. HIV resistance to zidovudine: the role of pyrophosphorolysis. Drug Resist. Updat. 2 (1999) 91-95
33. Boyer P.L., Sarafianos S.G., Arnold E., and Hughes S. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase. J. Virol. 75 (2001) 4832-4842
34. Meyer P.R., Matsuura S.E., Mian A.M., So A.G., and Scott W.A. A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase. Mol. Cell. 4 (1999) 35-43